We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$352M
AUM Growth
+$20.4M
Cap. Flow
+$7.89M
Cap. Flow %
2.24%
Top 10 Hldgs %
29.69%
Holding
186
New
11
Increased
65
Reduced
46
Closed
4

Top Buys

Rank Stock Value
1
HXL icon
Hexcel
HXL
+$7.21M
2
LULU icon
lululemon athletica
LULU
+$6.57M
3
EL icon
Estee Lauder
EL
+$6.19M
4
SPSC icon
SPS Commerce
SPSC
+$2.95M
5
DOW icon
Dow Inc
DOW
+$584K

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$8.36M
2
UNH icon
UnitedHealth
UNH
+$5.5M
3
WSM icon
Williams-Sonoma
WSM
+$4.11M
4
ICUI icon
ICU Medical
ICUI
+$2.81M
5
DD icon
DuPont de Nemours
DD
+$636K

Sector Composition

Rank Sector Weight
1 Healthcare 20.39%
2 Technology 17.1%
3 Industrials 11.09%
4 Consumer Discretionary 9.49%
5 Financials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
151
Vanguard S&P 500 ETF
VOO
$1.01T
$244K 0.07%
+907
New +$240K
ZBH icon
152
Zimmer Biomet
ZBH
$18.8B
$243K 0.07%
2,122
+13
+0.6% +$1.52K
MCHI icon
153
iShares MSCI China ETF
MCHI
$6.31B
$238K 0.07%
4,000
BX icon
154
Blackstone
BX
$107B
$235K 0.07%
+5,300
New +$211K
CL icon
155
Colgate-Palmolive
CL
$74.1B
$229K 0.07%
3,195
+6
+0.2% +$426
WTW icon
156
Willis Towers Watson
WTW
$31.6B
$228K 0.06%
1,189
DEO icon
157
Diageo
DEO
$51.6B
$224K 0.06%
1,300
UNH icon
158
UnitedHealth
UNH
$367B
$222K 0.06%
910
-22,850
-96% -$5.5M
NKE icon
159
Nike
NKE
$62.3B
$218K 0.06%
2,600
MNP
160
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
$218K 0.06%
14,650
JKHY icon
161
Jack Henry & Associates
JKHY
$11.2B
$215K 0.06%
1,605
MPC icon
162
Marathon Petroleum
MPC
$84B
$214K 0.06%
3,822
+24
+0.6% +$1.31K
WFC icon
163
Wells Fargo
WFC
$265B
$214K 0.06%
4,516
-1,661
-27% -$77.7K
EXC icon
164
Exelon
EXC
$46.7B
$204K 0.06%
5,980
+138
+2% +$4.87K
LRCX icon
165
Lam Research
LRCX
$383B
$203K 0.06%
+10,800
New +$205K
QQQ icon
166
Invesco QQQ Trust
QQQ
$479B
$203K 0.06%
+1,086
New +$200K
AMGN icon
167
Amgen
AMGN
$219B
$202K 0.06%
1,097
-119
-10% -$21.3K
AZN icon
168
AstraZeneca
AZN
$250B
$202K 0.06%
+2,450
New +$192K
EMR icon
169
Emerson Electric
EMR
$87.5B
$201K 0.06%
3,012
LUMN icon
170
Lumen
LUMN
$6.09B
$190K 0.05%
16,177
MIN
171
Aberdeen Intermediate Income Fund
MIN
$278M
$183K 0.05%
47,300
NEA icon
172
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.39B
$160K 0.05%
11,618
DTF
173
DTF Tax-Free Income 2028 Term Fund
DTF
$80.6M
$157K 0.04%
11,329
NXQ
174
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
$150K 0.04%
10,433
TCRT icon
175
Alaunos Therapeutics
TCRT
$4.86M
$115K 0.03%
131

Similar funds

Dixon Hubard Feinour & Brown's Q2 2019 Portfolio in Review

As of Q2 2019, Dixon Hubard Feinour & Brown held 186 positions worth $352M, up 6.1% from $332M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Dixon Hubard Feinour & Brown's Q2 2019 filing shows 11 new, 65 increased, 46 reduced and 4 closed positions. Its largest new stake was Hexcel: 99,185 shares worth $8.02M. The largest sale was Zebra Technologies, an estimated $8.36M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.

  • Dixon Hubard Feinour & Brown's largest Q2 2019 buy was Hexcel: 99,185 shares worth $8.02M.
  • Dixon Hubard Feinour & Brown added most to Alibaba in Q2 2019, an estimated $503K increase.
  • Dixon Hubard Feinour & Brown's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $5.5M.
  • Dixon Hubard Feinour & Brown fully exited Zebra Technologies in Q2 2019, selling an estimated $8.36M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 30% of its $352M portfolio in Q2 2019.
  • Dixon Hubard Feinour & Brown opened 11 new positions and closed 4 in Q2 2019.
  • Dixon Hubard Feinour & Brown's portfolio value rose 6.1% quarter-over-quarter to $352M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2019, filed 14 Aug 2019.